News By Tag Industry News News By Location Country(s) Industry News
|  New Market Report: Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019Recently published research from GlobalData, "Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019", is now available at Fast Market Research
By: Fast Market Research, Inc. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Scope The report provides information on the key drivers and challenges of the Narcolepsy Therapeutics market. Its scope includes - * Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Narcolepsy Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. * Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. * Analysis of the current and future competition in the seven key countries Narcolepsy Therapeutics market. * Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. * Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Narcolepsy Therapeutics market. * Analysis of key recent licensing and partnership agreements in Narcolepsy Therapeutics market Reasons to Get this Report The report will enhance your decision making capability. It will allow you to - * Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. * Develop business strategies by understanding the trends shaping and driving the global Narcolepsy Therapeutics market. * Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Narcolepsy Therapeutics market in future. * Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. * Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. * Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. * What's the next big thing in the global Narcolepsy Therapeutics market landscape? - Identify, understand and capitalize. Companies Mentioned in this Report: Bioprojet, Jazz Pharmaceuticals, Inc, Teva Pharmaceuticals Partial Table of Contents: 1 Table of Contents 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Narcolepsy Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Narcolepsy with Cataplexy 2.1.2 Narcolepsy without Cataplexy 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Quality of Life Parameters 2.3 Etiology and Pathophysiology 2.4 Signs and Symptoms 2.5 Diagnosis 2.5.1 Actigraphy 2.5.2 Multiple Sleep Latency Test (MSLT) 2.5.3 Polysomnography (PSG) 2.5.4 Hypocretin Test 2.6 Treatment and Management Options 2.6.1 Non-Pharmacological Treatment 2.6.2 Pharmacological Treatment 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 NarcolepsyTherapeutics - Market Characterization 3.1 Overview 3.2 Narcolepsy Therapeutics Market Size (2006-2011) - Global 3.3 Narcolepsy Therapeutics Market Forecast (2011-2019) - Global 3.4 Narcolepsy Therapeutics Market Size (2006-2011) - The US 3.5 Narcolepsy Therapeutics Market Forecast (2011-2019) - The US 3.6 Narcolepsy Therapeutics Market Size (2006-2011) - France 3.7 Narcolepsy Therapeutics Market Forecast (2011-2019) - France 3.8 Narcolepsy Therapeutics Market Size (2006-2011) - Germany 3.9 Narcolepsy Therapeutics Market Forecast (2011-2019) - Germany 3.10 Narcolepsy Therapeutics Market Size (2006-2011) - Italy 3.11 Narcolepsy Therapeutics Market Forecast (2011-2019) - Italy 3.12 Narcolepsy Therapeutics Market Size (2006-2011) - Spain 3.13 Narcolepsy Therapeutics Market Forecast (2011-2019) - Spain 3.14 Narcolepsy Therapeutics Market Size (2006-2011) - The UK 3.15 Narcolepsy Therapeutics Market Forecast (2011-2019) - The UK 3.16 Narcolepsy Therapeutics Market Size (2006-2011) - Japan 3.17 Narcolepsy Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Narcolepsy Therapeutics Market 3.18.1 Drivers for the Narcolepsy Therapeutics Market 3.18.2 Barriers for the Narcolepsy Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Narcolepsy Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Narcolepsy Therapeutics Market 4.3.1 Provigil (modafinil) 4.3.2 Nuvigil (armodafinil) 4.3.3 Xyrem (sodium oxybate) 4.4 Key Takeaway Full Table of Contents is available at: -- http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number